GV Investment Managers

GV Investment Managers is a private equity firm founded in 2000 and based in Stamford, Connecticut. The firm specializes in impact investing, private equity, and portfolio management services. It focuses on sectors such as life sciences, consumer products, enterprise solutions, cryptocurrency, climate technology, and frontier innovations. With Alphabet as its sole limited partner, GV Investment Managers primarily targets investments in North America and Europe. The firm collaborates with operating partners who assist startups in areas such as design, diversity and inclusion, talent acquisition, and engineering, while also facilitating connections with Google for technological support and expertise.

Choongsoon Bae Ph.D

Engineering Partner

Bulik-Sullivan Ph.D., Brendan

General Partner

Dame, Frederique

Partner

Faris, Karim B.

General Partner

Crystal Huang

Partner

Tom Hulme

General Partner and Head of Europe

Rosana Kapeller

Entrepreneur In Residence

John Lyman

Partner

Melahn, Laura

Partner

Nordlander, Erik

General Partner

David Reshef

Venture Partner

Robbins M.D., Ben

General Partner

Issi Rozen

Venture Partner

Siegler, M. G.

General Partner

Wheeler, Andrew

General Partner

Jeremy Whelchel

Engineering Partner

Sangeen Zeb

Partner

962 past transactions

Comanche Biopharma

Venture Round in 2023
Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

AMP

Series C in 2023
AMP is an AI technology company that modernizes recycling infrastructure through smart sortation solutions. The company focuses on maximizing resource recovery while minimizing labor costs for waste management operations. With numerous deployments globally, AMP aims to transform the economics of recycling.

Cerevance

Series B in 2023
Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom, the company utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, using a repository of over 15,000 human brain tissue samples. This platform provides detailed expression and epigenetic data, allowing Cerevance to identify promising therapeutic targets for central nervous system diseases. Through its research, the company aims to advance new medicines that can potentially address the underlying mechanisms of these debilitating conditions.

MoonHub

Seed Round in 2023
MoonHub is a provider of human capital services that aims to create economic opportunities for individuals globally. The company has developed the world's first AI Recruiter, which utilizes advanced AI technology and automation systems to enhance the recruitment process. By integrating these innovations with recruiting expertise, MoonHub offers staffing solutions that help recruiters efficiently identify and hire the right candidates for job openings. This combination of technology and human insight enables individuals to connect with suitable job opportunities, thereby streamlining the hiring process and improving overall recruitment outcomes.

Jetpack

Seed Round in 2023
Jetpack creates scalable cloud backend software for engineers to help them with coding and cloud services. The platform develops software that builds scalable web backends for the cloud and creates images and configurations directly from annotated python code.

Galileo

Series D in 2022
Galileo, Inc. is a technology company that specializes in providing healthcare solutions through a mobile application, enabling direct access to clinical care and expertise via smartphones. Founded in 2014 and headquartered in New York, the company facilitates communication between healthcare providers and patients using advanced telecommunications technologies. Galileo delivers high-touch, data-driven, multi-specialty care to a diverse patient population, offering services over the phone and in various settings. The company is recognized by regional and national health plans, employers, and major corporations for its effectiveness in enhancing population health. Galileo's mission is to address complex healthcare challenges and foster closer connections between patients and providers.

Flatfile

Series B in 2022
Flatfile Inc. is a company that specializes in data onboarding solutions, providing a platform that allows developers to efficiently validate, map, and import data from spreadsheets, such as CSV, XLS, and TSV files, into software applications. Their offerings include Portal, an import button embedded through a JavaScript snippet, and Concierge, which creates secure workspaces for collaboration on complex data ingestion tasks. The platform is designed to integrate seamlessly with a company's web application, enabling users to upload data easily while ensuring data quality through an intuitive validation process. Flatfile's API-first approach has gained the trust of numerous organizations, helping them streamline data import experiences and enhance developer productivity. Established in 2018 and based in Denver, Colorado, Flatfile continues to innovate in the field of AI-assisted data exchange.

Sardine

Series B in 2022
Sardine is a financial technology company that specializes in providing a risk and fraud infrastructure tailored for the online economy. It has developed a device intelligence platform that leverages artificial intelligence and advanced risk engine software. This platform enhances fraud detection while minimizing sign-up friction by analyzing multiple real-time data points, including device information, browser details, and behavioral biometrics. By integrating this technology, Sardine enables businesses to establish a robust risk and fraud management framework, ultimately reducing costs within the fintech ecosystem.

Pretzel Therapeutics

Series A in 2022
Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Omni

Series A in 2022
Omni is a multifaceted company based in San Francisco, California, that specializes in business intelligence, cybersecurity, and cloud engineering services. Its primary offering is a unique business intelligence platform that merges the reliability of a shared data model with the flexibility of SQL, allowing users to easily access, explore, and share curated data metrics. This platform is designed to streamline the data analytics process, enabling clients to focus on deriving meaningful insights without the complications often associated with data management. Additionally, Omni operates a rentals platform that connects local businesses with community members, providing access to a variety of rental items such as bikes, surfboards, and camping equipment. This initiative enhances community engagement by making diverse products readily available for short-term use.

Fractyl Health

Series F in 2022
Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.

Vicinitas Therapeutics

Series A in 2022
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Merlin Labs

Series B in 2022
Merlin Labs is an innovative company focused on creating autonomous flight technology for advanced air travel, primarily utilizing fixed-wing aircraft. Founded in 2018 and headquartered in Boston, Massachusetts, the company develops a sophisticated aircraft autonomy system that employs artificial intelligence and machine learning, akin to the technology used in driverless cars. This system aims to facilitate the pilotless transportation of goods and eventually people, establishing a new infrastructure for aerial mobility.

Xilis

Series A in 2022
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

SingleStore

Series F in 2022
SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics. The company offers a cloud database-as-a-service, known as SingleStore Managed Service, which enables analytics on the cloud of choice. Its flagship product, SingleStore DB, is a distributed SQL database that supports operational analytics on bare metal and hybrid cloud environments. SingleStore specializes in modernizing data platforms, securing government workloads, and facilitating IoT analytics, customer interactions, and risk management. It caters to a diverse range of industries, including financial services, media communications, energy, government, and retail. Founded in 2011 and headquartered in San Francisco, California, the company has additional offices in Seattle, Boston, Portland, Lisbon, and London. Initially known as MemSQL Inc., it rebranded to SingleStore, Inc. in October 2020.

Areteia Therapeutics

Series A in 2022
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

FYTO

Series A in 2022
FYTO, Inc. is a company based in Cambridge, Massachusetts, that focuses on developing plant-based feed production systems aimed at enhancing the sustainability of agriculture. Founded in 2019, FYTO specializes in creating nutrient-dense crops that require minimal resources, alongside cultivation and harvesting systems designed to ensure quality and consistency. The company's offerings include a variety of agricultural products such as animal feed, plant-based proteins, nutritional supplements, and bio-fertilizers. By adopting climate-friendly practices and methodologies, FYTO aims to support farmers globally in achieving improved economic and environmental outcomes in their agricultural operations.

Modular

Seed Round in 2022
Modular is an AI software developer platform that unifies the development and deployment of AI for everyone. The product breakthroughs will be powered by production quality infrastructure that brings together compilers and runtimes, is designed for heterogeneous computing, edge to datacenter distribution, and is focused on usability. Unifying software and hardware with a "just works" approach will save developers enormous time and increase their velocity.

Medallion

Series C in 2022
Medallion is a company that offers a network management platform tailored for the healthcare industry, focusing on simplifying the complex processes of licensing, credentialing, and payer enrollment. Founded in 2020 by Derek Lo and based in San Francisco, California, Medallion's all-in-one platform addresses the logistical challenges that healthcare providers and telemedicine companies face, enabling them to minimize time spent on administrative tasks. Key features of the platform include facilities for new licensing and renewals, primary source verification, continuing medical education tracking, and document management. By streamlining these processes, Medallion allows healthcare professionals to concentrate more on patient care rather than paperwork.

Sanas

Series A in 2022
Sanas is a technology company that specializes in real-time speech-understanding solutions designed to modulate accents while maintaining the natural quality of voices and emotions. Its platform aids multilingual speakers by offering accent correction, which facilitates effective communication and reduces language barriers. The technology is particularly beneficial for contact centers and enterprises, enhancing overall communication, improving customer satisfaction, and minimizing instances of miscommunication. By enabling users to communicate in their preferred accents without noticeable delays, Sanas fosters better understanding and interaction among diverse speakers.

Courier

Series B in 2022
Courier provides a notification management platform that allows developers to effectively route user notifications across various communication channels, such as email, SMS, and messaging apps. By utilizing an API, the platform intelligently determines the optimal channel for delivering messages based on user engagement and online status. This capability enables businesses to craft a single message that can be reused across multiple channels or customized for specific platforms, ensuring timely and relevant communication with users, business partners, and external stakeholders. With a commitment to customer success, Courier has evolved alongside technological advancements while maintaining stable management practices and long-term relationships with its clients.

Ahana

Series A in 2022
Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.

Sesame

Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Arch Data, Inc (fka Meltano)

Seed Round in 2022
Arch is an AI data analytics platform designed to deliver insights tailored to business needs, without requiring a full data team or complex toolchains. As an AI Data Analyst, Arch provides an all-in-one solution for extracting, analyzing, and visualizing data across your organization, ensuring you can make informed decisions quickly and confidently. Built to be intuitive and flexible, Arch is backed by human expertise for the highest accuracy, creating an invaluable resource for any size business looking to optimize performance, reduce costs, and drive growth. From real-time data insights to predictive analytics, Arch integrates seamlessly into your existing workflows, delivering insights wherever your teams operate—whether in Slack, email, or your CRM.

Nava

Series B in 2022
Nava is a health insurance brokerage based in New York, dedicated to providing high-quality and affordable healthcare solutions for employers and their employees. The company offers a range of services, including healthcare tools, year-round employee advocacy, and ongoing plan measurement. These services are designed to help clients select and manage their healthcare plans effectively, ensuring that they can offer necessary benefits while also reducing overall costs. Through its innovative approach, Nava aims to enhance the healthcare experience for both employers and employees.

Multiverse

Series D in 2022
Multiverse is an EdTech startup focused on providing an alternative to traditional university education through career-oriented apprenticeships. By matching young talent with professional services and digital roles, Multiverse aims to deliver relevant skills and applied learning experiences. The platform not only equips individuals with necessary competencies but also fosters the development of social capital and professional networks, empowering them to shape their own career paths. This approach offers a viable alternative to conventional university routes and standard corporate training programs, catering to the evolving needs of the workforce.

Strella Biotechnology

Series A in 2022
Strella Biotechnology, Inc. is a Philadelphia-based company that designs and manufactures sensor-based devices aimed at maximizing the freshness of produce throughout the supply chain. Founded in 2018 by Jacob Jordan and Katherine Sizov, the company specializes in ethylene detection technology, which assesses the ripeness of fruit by measuring the ethylene gas emitted during ripening. This innovation helps to optimize the produce supply chain by providing critical data that reduces spoilage and enhances the management of fresh produce. Strella Biotechnology leverages its patented technology to support efficiency and maintain quality in food distribution.

FarmWise

Series B in 2022
FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency. It offers a productive mechanical weeding implement for vegetable crops, along with its exceptional training and support program. The company was founded in 2016 and is based in San Francisco, California.

Gametime

Venture Round in 2022
Gametime is a mobile platform that specializes in selling last-minute tickets for a variety of live events, including sports, concerts, and theater, across the United States and Canada. The service simplifies the ticket purchasing process by curating a selection of the best available options from over 10,000 seats, allowing clients to choose from 50 top values. Each ticket option is accompanied by a high-resolution panoramic photo, providing users with a preview of the view from their chosen section. The platform features interactive seat maps that allow for easy comparison of prices and locations, enhancing the customer experience. Tickets are conveniently delivered directly to the user's phone, facilitating instant access to entertainment.

Motive

Series F in 2022
Motive is a technology company building technology to improve the safety, productivity, sustainability, and profitability of businesses that power the physical economy. Combined with AI, the Motive platform gives you complete visibility and control and significantly reduces manual workloads by automating and simplifying tasks. Motive serves small businesses across a wide range of industries, including transportation and logistics, construction, energy, field service, manufacturing, agriculture, food and beverage, retail, and the public sector. Motive is a fully unified integrated operations platform, combining driver safety, fleet management, equipment monitoring, and spend management all in one place.

Mirvie

Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

Invetx

Series B in 2022
Invetx, Inc. is a biotechnology company focused on developing protein-based therapeutics for animal health care and veterinary medicine. Based in Boston, Massachusetts, Invetx's team comprises veterinary scientists and clinicians dedicated to discovering and creating biotherapeutics for both pets and farm animals. The company aims to enhance health outcomes in the animal health industry by leveraging biopharma technologies, supported by a network of experts in animal and human health. Through its innovative platform, Invetx is committed to advancing a portfolio of therapies and technologies designed to improve animal care and well-being.

Graft

Pre Seed Round in 2022
Graft is a modern AI platform that allows data teams to create production-ready AI solutions with minimal effort. It eliminates the need for machine learning expertise, additional staffing, or infrastructure maintenance. The platform focuses on a data-centric approach, utilizing foundation models to enhance business outcomes. Additionally, Graft specializes in unstructured data analysis, harnessing artificial intelligence to process various types of data, including text, images, video, audio, and graphs. This capability enables clients to apply advanced analytical techniques effectively, ultimately driving improved results for their businesses.

Aspen Neuroscience

Series B in 2022
Aspen Neuroscience, Inc. is a biotechnology company focused on developing induced pluripotent stem cells (iPSCs) to create patient-specific therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018 and based in San Diego, California, the company is advancing its pipeline of products, which includes ANPD001, an autologous neuron replacement therapy for sporadic Parkinson's disease, and ANPD002, a gene-edited autologous neuron replacement therapy targeting familial forms of the disease. Aspen Neuroscience employs innovative genomic approaches in conjunction with stem cell biology to address diseases with significant unmet medical needs, aiming to provide restorative cell therapies that can modify the progression of Parkinson's disease and potentially extend to other affected organs.

deepset

Series A in 2022
Deepset is a company specializing in natural language processing (NLP) solutions, focusing on leveraging the latest advancements in machine learning to create real-world applications. It is known for developing the Haystack open-source framework, which facilitates the deployment of NLP tasks, and for offering deepset Cloud, a platform designed for enterprise AI teams. Since its inception in 2018, deepset has supported numerous AI teams globally by providing reliable, open-source technology and tailored solutions. The company's software emphasizes the use of transfer learning to enhance model performance while minimizing the amount of training data required, thereby enabling users to unlock value from diverse text sources effectively.

OMass Therapeutics

Series B in 2022
OMass Therapeutics Limited is a biotechnology company based in Oxford, United Kingdom, that specializes in drug discovery through structural mass spectrometry. Founded in 2016, the company employs innovative mass spectrometry platforms to develop therapeutics aimed at difficult disease targets. By providing access to native mass spectrometry, OMass Therapeutics enables clients in the biotechnology and pharmaceutical sectors to study complex protein assemblies and their interactions with other biological molecules. This approach allows clients to address challenging drug targets and biotherapeutics more effectively, fostering a collaborative environment for advancing novel medicines.

Waltz Health

Series A in 2022
Waltz Health is focused on enhancing the pharmaceutical supply chain by collaborating with consumers, payers, and pharmacies to develop innovative, technology-driven solutions for pricing, distribution, and prescription of medications. The company creates AI-driven marketplaces that aim to reduce costs and provide valuable insights for users, facilitating informed decision-making in prescription care. By offering consumer tools designed to empower individuals and help payers manage their pharmacy benefits, Waltz Health strives to improve accessibility and affordability in the healthcare sector.

Rooser

Series A in 2022
Rooser is a business-to-business platform based in Edinburgh, Scotland, that facilitates seafood trade across Europe. The company provides a cloud-based marketplace specifically for fresh fish, allowing seafood buyers and suppliers to connect and engage in efficient commerce. Rooser's platform simplifies the trading process by enabling users to negotiate prices and manage deliveries effectively, thus enhancing the overall efficiency of seafood transactions in the market.

Gravity Sketch

Series A in 2022
Gravity Sketch is a London-based company founded in 2014 that specializes in developing virtual reality and 3D design software. Its intuitive multi-platform tools are designed to enhance the efficiency and effectiveness of creating three-dimensional products across various industries, including transportation, industrial design, apparel, and footwear. The platform facilitates the entire design process, allowing users to trace their ideas from initial conception to finalization in an engaging and straightforward manner. By streamlining workflows and fostering collaboration among cross-functional teams, Gravity Sketch aims to reduce friction in traditional design practices, ultimately enabling faster and more cost-effective creative processes.

Viz

Series D in 2022
Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat them. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce the time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California.

StackBlitz

Seed Round in 2022
StackBlitz is a developer of an integrated software used to offer comprehensive facilities to computer programmers for software development. Its software consists of a source code editor, build automation tools, and a debugger for creating sharing live projects that enable clients to get started with angular or react project without the need to deal with the installation of dependencies. The company also allows the developer to edit offline and tweak the application in real-time without page refresh and preserving the application state.

Rattle

Series A in 2022
Rattle is a company that specializes in developing integration technology for Salesforce, facilitating seamless interaction between systems and users within platforms such as Slack and Teams. This revenue orchestration platform caters to all customer-facing departments, allowing sales representatives to log calls, track key metrics, and update opportunities with ease. Additionally, it enables account executives and sales development representatives to maintain customer relationship management systems while providing real-time visibility into pipeline reports. This functionality empowers marketing professionals to focus on engaging with customers rather than managing internal processes. Rattle was co-founded in 2020 by Sahil Aggarwal, Apoorva Verma, and Milan Singh.

Obsidian Security

Series C in 2022
Obsidian Security, Inc. develops cloud infrastructure and data center security solutions, focusing on cybersecurity and artificial intelligence to address cyber threats in hybrid-cloud environments. The company provides a platform that enables threat detection, breach remediation, and security hardening specifically for business-critical software as a service (SaaS) applications. By delivering cloud detection and response capabilities, Obsidian Security aims to enhance the security posture of enterprises. Founded in 2017 and headquartered in Newport Beach, California, the company is dedicated to creating a comprehensive understanding of interconnected applications to ensure their safety and security.

Brightline

Series C in 2022
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Celsius Therapeutics

Series B in 2022
Celsius Therapeutics is a biotechnology company focused on developing precision medicines for patients with cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a team of scientists, technologists, computational biologists, clinicians, and drug hunters. Utilizing single-cell genomic analysis and machine learning techniques, Celsius Therapeutics aims to discover and create innovative therapies that can lead to significant improvements in patient outcomes. The company's research efforts are centered on identifying new drug candidates that address unmet medical needs in the therapeutic landscape.

Digits

Series C in 2022
Digits is a fintech company building tools for businesses and finance professionals by leveraging its proprietary Living Model technology. The company was founded by Wayne Chang and Jeff Seibert in 2018 and is headquartered in San Francisco, California, United States.

LifeMine Therapeutics

Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated platform that combines genomics, artificial intelligence, and synthetic biology. This innovative Avatar-Rx platform utilizes high-throughput microbiology, data science, machine learning, genome engineering, and automation to explore the fungal biosphere for novel genetically encoded molecules with specific biological functions. By integrating chemoinformatic-assisted drug optimization and advanced chemical synthesis with biotransformation, LifeMine Therapeutics aims to advance a pipeline of new medicines into development.

Spotlight Therapeutics

Series B in 2022
Spotlight Therapeutics, Inc. specializes in the development of gene editing therapeutics designed to target specific cell populations directly within the body. Established in 2017 and based in Hayward, California, the company leverages a biotechnology platform that utilizes CRISPR nuclease effectors for in vivo gene editing. Its innovative approach aims to create next-generation programmable nucleases that enhance treatment options for a variety of conditions. Spotlight Therapeutics is focused on multiple therapeutic areas, including immuno-oncology, ophthalmology, and hematology, and is developing programs to address previously undruggable intracellular gene targets as well as specific monogenic disease targets related to the eye. This targeted gene editing strategy seeks to overcome the challenges associated with traditional delivery methods, thereby providing healthcare providers with improved tools for patient treatment.

Agolo

Series A in 2022
Agolo, Inc. is a New York-based company that specializes in developing an artificial intelligence platform designed to create real-time summaries from unstructured information. Utilizing machine learning and natural language processing, Agolo's technology transforms messy data into a clean, structured format, enabling various enterprise applications such as business intelligence dashboards and support site augmentation. The platform helps organizations enhance their product quality, reduce support costs, and quickly identify emerging issues by providing clear insights into customer experiences. Established in 2012 and formerly known as Ninoh, Inc., Agolo serves a diverse range of industries, empowering professionals to efficiently analyze large volumes of data and make informed decisions based on comprehensive summaries.

Nothing

Series B in 2022
Nothing is a consumer electronics company that designs and manufactures smartphones, earbuds, and other connected devices. The company emphasizes creating a seamless digital ecosystem by integrating hardware and software to enhance user experience. Its product offerings include mobile phones and personalized noise-cancellation earbuds equipped with features such as wireless charging, water resistance, and dual connectivity. Nothing aims to eliminate barriers between people and technology, providing reliable and durable electronic devices at affordable prices.

DNAnexus

Series H in 2022
DNAnexus, Inc. is a provider of cloud-based genome informatics and data management tools aimed at enterprises engaged in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and integration with clinical and phenotypic data, promoting seamless collaboration among users. Key offerings include MOSAIC Microbiome, a platform for collaborative microbiome research; DNAnexus Apollo, which focuses on clinico-genomic data exploration; and DNAnexus Titan, a comprehensive data analysis solution. Additionally, DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration. The Clinico-Genomic Data Solution program addresses the need for disease-specific datasets by building networks with healthcare partners to enhance diagnosis and treatment pathways. DNAnexus serves a diverse client base, including biopharmaceutical companies, genome centers, and diagnostic test providers, and has established a strategic alliance with WuXi NextCODE Genomics. The company also maintains additional offices in San Francisco, London, and Prague.

Bonnet

Venture Round in 2022
Bonnet Ltd. is a London-based company founded in 2019 that specializes in a charging-as-a-service platform for electric vehicle drivers. The company addresses the challenges faced by drivers who must register separately for multiple public charging networks by offering a single app that enables access to any public charger. This streamlined service caters to both individual drivers and businesses, simplifying the charging process and enhancing the overall user experience for electric vehicle owners.

Optiwatt

Seed Round in 2022
Optiwatt is a developer of a monitoring application that helps electric vehicle (EV) owners understand the costs associated with charging their vehicles at home. The platform connects home electricity rate data with EV battery metrics, allowing users to see the cost of each charge and track their electric utility expenses based on their home address. By providing insights into real-time electricity rates, Optiwatt enables users to forecast their charging costs and calculate the savings achieved by driving electric compared to traditional gasoline vehicles. Additionally, the application aims to alleviate range anxiety by offering charge forecasting features, ensuring users are informed about their charging needs and expenses.

dbt Labs

Series D in 2022
Dbt Labs is a developer of an open-source analytics engineering tool aimed at empowering data analysts to create and share organizational knowledge. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, the company provides a platform that enables users with SQL expertise to develop data transformation workflows efficiently. Its transformation workflow tool supports collaborative deployment of analytics code, adhering to software engineering practices such as modularity, portability, and thorough documentation. By facilitating data modeling, Dbt Labs helps teams streamline their analytics processes and enhance their data-driven decision-making capabilities.

Redpanda Data

Series B in 2022
Redpanda Data is a company that provides a modern streaming data platform designed to handle large data streams effectively. Its platform allows users to record both real-time and historical enterprise data, making it a valuable tool for organizations that require efficient data management. Redpanda's architecture features a compatible application programming interface and is deployable as a single binary, which simplifies the deployment process. Additionally, it includes a built-in schema registry and operates without external dependencies, enhancing performance and reliability for developers. This combination of features enables enterprises to maintain their software stacks while improving data processing capabilities.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Helium

Series D in 2022
Helium Systems Inc. develops Internet-of-Things (IoT) technology, focusing on sensor devices that monitor environmental factors such as temperature, humidity, barometric pressure, motion, and light. These sensors are utilized in various applications, including facility monitoring and quality control for medical products, energy management, air quality assessment, and refrigeration temperature regulation. The company offers a web and mobile dashboard for users to manage and access sensor data. Additionally, Helium operates a decentralized wireless network that enables low-power IoT devices to connect to the internet. This network incentivizes individuals to become network operators, rewarding them with a cryptocurrency for validating network transactions and contributing to the network's integrity. Incorporated in 2013 and based in San Francisco, Helium Systems continues to innovate within the IoT landscape, enhancing the ability to gather insights from smart devices.

Overview.ai

Series A in 2022
Overview’s inspection systems are built with Deep Learning technology which allows us to find mistakes more consistently and in a wider variety of situations.

Voltron Data

Series A in 2022
Voltron Data specializes in developing tools for data access and memory computing aimed at enhancing the data analytics ecosystem. The company has created an open-source platform that facilitates seamless connections between data, hardware, and developers. By providing modular and composable analytics building blocks, Voltron Data enables the creation of multi-language tools that promote accelerated data interchange and in-memory processing. This approach allows developers, data scientists, and data engineers to improve their toolchains and establish better interoperability standards for data access, preparation, cleaning, analytics, and feature engineering.

Genesis Global

Series C in 2022
Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Voltron Data

Seed Round in 2022
Voltron Data specializes in developing tools for data access and memory computing aimed at enhancing the data analytics ecosystem. The company has created an open-source platform that facilitates seamless connections between data, hardware, and developers. By providing modular and composable analytics building blocks, Voltron Data enables the creation of multi-language tools that promote accelerated data interchange and in-memory processing. This approach allows developers, data scientists, and data engineers to improve their toolchains and establish better interoperability standards for data access, preparation, cleaning, analytics, and feature engineering.

Homebound

Series C in 2022
Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human. Born out of the 2017 Northern California wildfires, Homebound was created by a local team of construction, real estate, design and technology experts who set out to create a better homebuilding solution for friends, family and neighbors affected. Homebound is the first homebuilder to manage the entire building process for homeowners and support them every step of the way — from insurance negotiation and architecture all the way to permitting, construction and move-in. Through easy-to-use technology and a network of vetted building experts, Homebound is simplifying the rebuilding process and alleviating the stress, complexity and uncertainty homeowners face after a natural disaster.

Neo.Tax

Series A in 2022
Neo.Tax, based in Mountain View, California, offers tax preparation and automation services through its innovative software platform. The company focuses on simplifying the often complex process of applying for the Research and Development (R&D) tax credit, especially in light of recent tax law changes regarding R&D capitalization. By leveraging machine learning algorithms, Neo.Tax automates the collection and organization of data from various sources, including emails, documents, and financial systems, which streamlines the tax filing process. Their platform is designed to assist both early-stage startups and larger public companies, ensuring they are audit-ready and capable of optimizing their tax liability. Through its solutions, Neo.Tax aims to alleviate common challenges faced by finance teams in accurately documenting activities and expenses related to tax credits.

Ventus Therapeutics

Series C in 2022
Ventus Therapeutics is a biopharmaceutical company focused on discovering and developing novel small molecule medicines aimed at treating autoimmune diseases, inflammatory diseases, and cancer by targeting the innate immune system. The company employs a structural immunology platform that provides deep insights into the mechanisms and molecular structures involved in immune responses. This platform integrates proprietary protein engineering capabilities with advanced rational and structure-based drug design tools, allowing for precise targeting of the innate immune system. Ventus is actively building a pipeline of drug programs that address critical targets within this system, particularly proteins involved in inflammasome and nucleic acid-sensing signaling pathways, thereby enabling the treatment of both acute and chronic inflammatory and immune-related conditions.

Scandit

Series D in 2022
Scandit AG is a technology company based in Zurich, Switzerland, specializing in mobile computer vision and augmented reality solutions for enterprises. Founded in 2009, Scandit develops barcode scanning software that enhances scanning performance across various devices, including smartphones, tablets, and wearables. Its offerings include the Scandit Keyboard Wedge, Barcode Scanner SDK for the Web, and MatrixScan, which improve processes in retail, logistics, healthcare, and manufacturing. The company's solutions enable functionalities such as mobile shopping, self-checkout, inventory management, and asset tracking, while also facilitating contactless interactions. Scandit's products are utilized by notable clients such as 7-Eleven, Carrefour, and Johns Hopkins Hospital. By leveraging proprietary technology in computer vision and machine learning, Scandit aims to streamline operations, reduce costs, and enhance customer experiences across multiple industries. The company also maintains offices in San Francisco, Boston, London, and Warsaw.

Seismic Therapeutic

Series A in 2022
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Lacework

Venture Round in 2022
Lacework, Inc. is a cloud security company based in Mountain View, California, founded in 2015. The company provides a comprehensive security platform that automates threat defense and intrusion detection for cloud workloads. Its flagship solution, Polygraph, secures customer accounts, workloads, and data by integrating with cloud providers' security measures. Lacework's platform continuously monitors all cloud components, including workloads, applications, processes, containers, and user accounts, offering features such as configuration assessment, behavior monitoring, anomaly detection, and incident investigation. This enables security teams to effectively protect data and maintain compliance while allowing businesses to innovate rapidly and safely in the cloud.

Pecan

Series C in 2022
Pecan operates a predictive analytics platform that empowers businesses to forecast critical outcomes effectively. It utilizes a low-code interface that simplifies the predictive modeling process, allowing companies to generate accurate predictions without needing in-house data scientists or engineers. Pecan automates data preparation and feature engineering, enabling users, particularly SQL-trained business intelligence analysts, to create tailored predictive models quickly. The platform supports various industries, including fintech, insurance, retail, and consumer services, by providing pre-built models and templates that align with specific business objectives. This capability allows organizations to enhance customer lifetime value, retention, conversion rates, and demand forecasting. Pecan's solutions have a significant financial impact, influencing billions of dollars in revenue across various sectors.

Synapticure

Seed Round in 2022
Synapticure is a virtual clinical care platform dedicated to supporting patients with neurodegenerative diseases, including dementia, Parkinson's, and ALS, throughout the United States. Founded by patients, the company offers comprehensive care services that include access to disease-specific neurologists, speech and language therapy, and 24/7 care coordination. Utilizing advances in science, technology, and computational analytics, Synapticure ensures that patients receive tailored treatment and support in their own homes. The platform integrates medical, dental, vision, and life insurance plans to facilitate easy access to a range of healthcare services, including behavioral health support such as psychiatry and therapy, all aimed at enhancing the quality of life for individuals facing these challenging conditions.

TenSixteen Bio

Series A in 2022
TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases. The company uses somatic mosaicism and clonal hematopoiesis (CHIP) to find and develop new treatments for age-related disorders. Foresite Labs co-founded TenSixteen Bio, which is based in San Francisco.

Censys

Series B in 2022
Censys, Inc. specializes in internet scanning and asset identification solutions, offering a platform that enables organizations to gain a real-time view of global networks and devices. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides tools for attack surface management, allowing users to discover unknown assets, monitor remote workforces, and identify threat actors. Its internet intelligence platform is designed for threat hunting and exposure management, creating a comprehensive dataset that enhances visibility into vulnerabilities and internet-exposed infrastructure. This enables businesses to efficiently locate and manage the devices, networks, and infrastructure that are critical to their operations.

Leyden Labs

Series B in 2022
Leyden Labs is focused on developing intranasal products that aim to protect individuals from respiratory viruses, including those in the influenza and coronavirus families. The company's innovative approach targets common characteristics across various viral families, allowing for simultaneous protection against multiple viruses rather than just specific variants, as is the case with traditional vaccines. This strategy seeks to empower individuals to safeguard themselves from infections and reduce the transmission of these diseases. Leyden Labs is driven by a team of experienced biotechnology professionals who are committed to advancing solutions that alleviate the impact of respiratory viruses on public health.

Voltage

Seed Round in 2022
Voltage is a Bitcoin infrastructure provider. It adds enterprise-grade capabilities to both Layer 1 and Layer 2 technologies. It provides Bitcoin-centric infrastructure to engineering teams, enabling enterprise-grade experiences. Users benefit from the fastest and most scalable Lightning solution that meets the highest security and privacy standards by leveraging Voltage. Users can build, deploy, and scale faster than ever before with modern modular tools and processes. Voltage brings to market a suite of node, liquidity, and data services that elevates your value proposition via Lightning Network architecture.

Agtonomy

Seed Round in 2022
Agtonomy is a platform that combines hybrid autonomy and tele-assistance to provide advanced AI solutions for the agricultural sector. The company addresses significant challenges faced by farmers, including labor shortages, sustainability issues, and decreasing profit margins. By collaborating with established equipment manufacturers, Agtonomy converts traditional tractors and agricultural machinery into autonomous and remote-controlled systems. This transformation allows local farmers to enhance their operational efficiency and adaptability while managing limited budgets and seasonal pressures. Through its innovative approach, Agtonomy aims to empower farmers and improve agricultural productivity.

Verana Health

Series E in 2022
Verana Health, Inc. is a digital health data company based in San Francisco, California, that focuses on enhancing the connection between patient care and clinical research through advanced analytics and real-world healthcare data. The company provides a comprehensive platform that integrates data from over 20,000 healthcare providers and 70 electronic health record systems, leveraging its AI-enhanced population health data engine, VeraQ™, to deliver insights derived from nearly half a billion health encounters. Verana Health also offers a suite of products, including the SightBook mobile application, which enables patients to test their vision and share results with their physicians in real time, facilitating timely appointment scheduling and treatment. By utilizing proprietary curated datasets, Verana Health supports life sciences partners in improving evidence generation, optimizing drug and device development, and enhancing the quality of care provided to patients. Founded in 2008 and previously known as Digisight Technologies, Inc., the company rebranded to Verana Health in 2018.

Lapse

Seed Round in 2021
Lapse is a social disposable camera app. The app lets close groups recreate the magic of old-school disposable cameras by taking 36 snaps to ‘rolls’ in private group chats.

Found

Series B in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Cockroach Labs

Series F in 2021
Cockroach Labs, Inc. is a developer of open-source database software, primarily known for its distributed SQL database, CockroachDB. Founded in 2015 and headquartered in New York, with an additional office in Cambridge, Massachusetts, the company provides a cloud-native platform designed for modern application development. CockroachDB allows organizations to build scalable applications that can withstand various types of failures, including those at the disk, machine, rack, and datacenter levels, with minimal disruption and no manual intervention. The database supports strongly consistent ACID transactions and offers an SQL API for data manipulation and querying. Its software is utilized by a diverse range of customers, from startups to Fortune 500 companies, across various industries, providing enterprise-grade disaster recovery services and enabling rapid development without compromising on consistency.

Dialpad

Series F in 2021
Dialpad, Inc. is a cloud-based communications platform that specializes in enterprise communication solutions. The company offers a range of services, including voice, video, group messaging, SMS, MMS, conferencing, and document sharing, all designed to facilitate secure collaboration for remote teams. Dialpad’s product offerings include Dialpad, Dialpad Sell, UberConference, and Dialpad Contact Center, all powered by advanced VoiceAI technology. These tools provide features such as real-time transcription, automated note-taking, live sentiment analysis, and voice analytics, which enhance communication and decision-making within organizations. Established in 2002 and based in San Francisco, Dialpad serves a diverse clientele, including notable companies like Motorola Solutions and Warby Parker. The company was formerly known as Switch Communications, Inc. before rebranding in 2016, and it maintains strategic alliances, including one with SoftBank Corp.

Synthesia

Series B in 2021
Synthesia Ltd. is a London-based company that specializes in an artificial intelligence-driven video production platform. Founded in 2017, the company offers a service that transforms text into professional-quality videos featuring customizable avatars and voiceovers in over 140 languages. Its innovative video synthesis technology allows users to create high-end videos for various applications, including personalized advertising, corporate communications, e-learning, and marketing. By synchronizing lip movements with new dialogue tracks, the platform facilitates the translation of video content into different languages, thereby enhancing distribution channels. Users can quickly create, edit, and share studio-quality videos directly in their browser, utilizing fully cloneable AI video templates to streamline production and meet diverse content needs.

Wonder

Series A in 2021
Wonder is a company that operates in two distinct sectors: gaming and food delivery. In the gaming industry, Wonder develops an all-in-one platform specifically for Android mobile devices, enabling users to play, stream, and share games seamlessly across different devices, thus enhancing the overall gaming experience. In the food delivery sector, Wonder runs truck-based restaurants that allow consumers to order food via a mobile app. These trucks are dispatched to locations near users’ homes, where they prepare meals on-site to ensure freshness and quality in deliveries. This dual focus on technology and culinary services positions Wonder uniquely in the market, catering to diverse consumer needs.

Universe

Series B in 2021
Universe is a mobile application that enables users to create websites, online shops, and portfolios. The platform provides essential tools, including a payment block for processing transactions and an order management system to streamline financial operations. By facilitating the building of digital presence and supporting e-commerce activities, Universe aims to simplify the online selling experience for individuals and businesses alike.

Quartet Health

Corporate Round in 2021
Quartet Health, Inc. is a healthcare technology company that operates a cloud-based platform designed to enhance communication and collaboration between medical and behavioral health providers. Founded in 2014 and based in New York, the platform integrates with health plans and systems to deliver actionable insights and reports on behavioral health conditions, ultimately aiming to improve patient outcomes. By facilitating connections among physicians, mental health providers, and insurers, Quartet Health enhances access to mental health care that aligns with patients' preferences and clinical needs, while also supporting tools for patient self-management. This approach not only improves the quality of care but also contributes to lowering healthcare costs for patients.

Groundswell

Seed Round in 2021
Groundswell operates a software-as-a-service platform focused on enhancing corporate philanthropy by enabling businesses to establish donor-advised funds for their employees. This platform allows companies to create personalized foundations for their staff and facilitates payroll matching for employee contributions. Additionally, Groundswell provides users with tools designed for effective philanthropic engagement, including tax-free investment options, customized giving opportunities, frictionless donation processes, and comprehensive impact reporting. By empowering employees to participate in charitable giving, Groundswell helps organizations manage their corporate social responsibility initiatives and fosters a culture of philanthropy within the workplace.

Upbound

Series B in 2021
Upbound, Inc. is a technology company that specializes in multi-cloud solutions, enabling organizations to manage and optimize their operations across various cloud environments as a cohesive unit. Founded in 2017 and based in Seattle, Washington, Upbound's platform is powered by Crossplane, allowing platform engineers to create, deploy, and operate internal developer platforms with enhanced control and self-service capabilities. The company provides tools for automation, cost optimization, capacity overflow, failover, and policy enforcement, helping organizations to streamline their multi-cloud deployments. Additionally, Upbound offers Universal Crossplane (UXP), which includes security features, support, and a range of official providers, further enhancing the flexibility and efficiency of cloud management for its users.

Vercel

Series D in 2021
Vercel Inc. is a cloud platform company that specializes in on-demand deployment and hosting services for frontend applications. Established in 2015 and based in Walnut, California, Vercel provides solutions for developing, previewing, and shipping Jamstack sites, enhancing the deployment process for developers. The platform integrates with popular version control systems, such as GitHub, Bitbucket, and GitLab, allowing for automatic project deployment from pull requests and merge requests. Vercel's infrastructure supports the hosting of static websites and serverless functions, optimizing performance through a content delivery network. Formerly known as ZEIT, Inc., the company rebranded to Vercel in April 2020, reflecting its focus on streamlining the development and deployment experience for frontend teams.

Farmers Business Network

Series G in 2021
Farmers Business Network, Inc. is an independent agricultural technology and commerce platform that connects farmers through a farmer-to-farmer network. It aims to enhance the economic viability of farms and promote sustainable practices. By leveraging data science, FBN provides agronomic insights, enabling farmers to make informed decisions regarding their crops and operations. The platform allows members to share information, purchase inputs directly from manufacturers, and navigate the market more effectively. Additionally, FBN assists farmers in selling their crops independently and offers various insurance options. With over 800 employees, Farmers Business Network supports members who collectively farm more than 80 million acres across the United States, Canada, and Australia, with headquarters in multiple locations including California, Illinois, South Dakota, Alberta, and Perth.

mabl

Series C in 2021
Mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, founded in 2016. It offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. The platform provides scriptless testing and integrates seamlessly into the continuous integration and continuous deployment (CI/CD) development lifecycle, allowing software teams to create and maintain reliable, auto-healing tests. By streamlining the testing process, Mabl enables organizations to enhance the speed and quality of their software releases, facilitating faster delivery of high-quality applications while helping developers and testers address bugs before they reach production.

Ankyra

Series B in 2021
Ankyra is a biotechnology company focused on developing anchored immunotherapy for cancer treatment. The company addresses the limitations of traditional cytokine therapies, which are often restricted due to widespread immune activation and associated toxicity. Ankyra's innovative approach involves the use of its Anchored Immunotherapy Platform to create ANK-101, a stable complex of a modified IL-12 cytokine and aluminum hydroxide, an FDA-approved adjuvant. This combination allows for targeted intratumoral delivery, enhancing the localized retention and activity of IL-12 while reducing systemic side effects. By optimizing the therapeutic potential of anchored immunotherapy, Ankyra aims to improve treatment outcomes for cancer patients, offering a safer and more effective alternative to conventional therapies.

Signos

Series A in 2021
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Infinitus Systems

Series B in 2021
Infinitus Systems is an AI healthcare company focused on automating phone-based processes to enhance efficiency within the healthcare ecosystem. By streamlining tedious and time-consuming communication tasks, Infinitus aims to improve access to therapy, adherence, and affordability for patients. The company's innovative tool allows users to submit call requests easily, track updates, and receive notifications upon task completion. Infinitus Systems has raised $51.4 million in funding from prominent investors, including Kleiner Perkins, Coatue, and Google Ventures. Through its automation solutions, the company seeks to reduce the complexity and costs associated with back-office administration in the healthcare sector.

Yellowbrick Data

Series C in 2021
Yellowbrick Data was founded in 2014 by experts in database and flash memory technologies to simplify data warehousing. They wanted to solve the challenges of high availability, running complex mixed workloads, support for ad-hoc SQL, computing correct answers on any schema, massive scalability and supporting large numbers of concurrent users. Yellowbrick Data empowers companies to make faster decisions with all of their data. Built for enterprises and the hybrid cloud, the Yellowbrick Data Warehouse deploys powerful analytics anywhere, with best-in-class economics.

Antiva Biosciences

Series D in 2021
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.

Cambridge Epigenetix

Series D in 2021
Cambridge Epigenetix aims to change the way medicine is practiced by reducing several routine and important diagnostic screening and detection tests for colorectal cancer and other common tumours to a simple blood draw. CEGX is pioneering the field of clinical epigenetics, and the company’s technology has proven the link between the epigenetic DNA modification 5-hydroxymethylcytosine (5hmC) and disease. Research has revealed a wide range of diagnostic and prognostic applications for 5hmC, now one of the most important biomarkers in the quest to improve human health. Spun-out of the University of Cambridge in 2012, CEGX was founded to develop and commercialise the science of world leading researchers Professor Sir Shankar Balasubramanian, co-inventor of Solexa sequencing, and Professor Anjana Rao, who identified the essential role of the TET enzymes and 5hmC in development and disease. A privately held company headquartered in Cambridge, UK, Cambridge Epigenetix is supported by several high-profile investors: GV (Google Ventures), Sequoia, Syncona, New Science Ventures, Ahren Innovation Capital, DNA Capital and the University of Cambridge.

Patina

Series A in 2021
Patina is a healthcare provider focused on enhancing the aging experience for older adults and their families. The company has developed a care model that prioritizes the unique needs and values of this demographic. By offering personalized and on-demand services, Patina aims to create a healthcare experience that is both human-centered and supportive. This approach allows families to actively participate in the care of their loved ones, ensuring that older adults receive the attention and respect they deserve as they navigate the challenges of aging. Patina's mission is to empower individuals to live their best lives and maintain their dignity as they age.

Modern Age

Series A in 2021
Modern Age is a health & wellness platform that makes the journey of aging easier, healthier, and manageable by one own self.

Flock Freight

Series D in 2021
Flock Freight is reimagining and reinventing the freight industry by relentlessly eliminating inefficiency and waste through algorithmic pooling. Working at the intersection of cutting-edge technology and human-centric logistics management, Flock Freight tailors its shipping experience to meet your business’s needs. Flock Freight seamlessly pools any freight to find the perfect route, avoiding terminals and risky offloads so that a shipment travels safely and directly to its destination, damage-free. The result: on-time delivery with every shipment—guaranteed. With venture capital from Google Ventures and SignalFire, Flock Freight is one of the largest startups in San Diego, California. The company's team is obsessed with aggressively growing its customer base, constantly improving the technology platform, and delivering a superior customer experience. Flock Freight aims to fundamentally change the $60 billion LTL freight industry across North America with FlockDirect—one pooled shipment at a time.

Resistant AI

Series A in 2021
Resistant AI specializes in fraud prevention software aimed at safeguarding automated financial systems from manipulation and attacks. The company develops solutions that protect vital processes such as online credit scoring, fraud detection, and anti-money laundering systems from organized fraudsters. By focusing on the risks associated with machine learning and artificial intelligence, Resistant AI assists banks, insurance companies, and e-commerce entities in securing their digital transactions. Their technology enables these organizations to implement identity forensics, thereby enhancing the integrity of automated financial services and mitigating the threats posed by advanced fraud.

RightHand Robotics

Venture Round in 2021
RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.